Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perenlei Enkhbaatar

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Critical Care Medicine|November 19, 2016
Cellular Therapy for Sepsis: A New Hope?Perenlei Enkhbaatar
Critical Care Medicine|August 28, 2013
Beta-1 blockade in sepsis: what to expect?Perenlei Enkhbaatar
Critical Care Medicine|September 25, 2013
Activated protein C: from excitement to disappointment?Perenlei Enkhbaatar
Critical Care Medicine|June 20, 2012
Differential host response to Burkholderia pseudomallei: tissue plasminogen activator*Perenlei Enkhbaatar, Daniel L Traber
Clinical Science (London, England : 1979)|May 21, 2004
Pathophysiology of acute lung injury in combined burn and smoke inhalation injuryPerenlei Enkhbaatar, Daniel L Traber
Critical Care Medicine|April 7, 2007
Interleukin-1 in thermal injury: what is next?Perenlei Enkhbaatar, Lillian Traber, Daniel Traber
Critical Care Medicine|June 10, 2004
Protective role of myocardial heat shock protein 70 in burn trauma: another brick in the wall?Martin Westphal, Perenlei Enkhbaatar, Daniel L Traber
Critical Care (London, England)|August 21, 2009
Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?Sebastian Rehberg, Perenlei Enkhbaatar, Daniel L Traber
Critical Care Medicine|December 28, 2012
AMP-activated protein kinase signaling pathway in toxic smoke inhalation injury: nice to demonstrate, nice to know, but is there a therapeutic relevance?Sebastian Rehberg, Perenlei Enkhbaatar, Daniel L Traber
Critical Care (London, England)|October 3, 2008
Anticoagulant therapy in acute lung injury: a useful tool without proper operating instruction?Sebastian Rehberg, Perenlei Enkhbaatar, Daniel L Traber
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Critical Care Medicine|November 19, 2016
Cellular Therapy for Sepsis: A New Hope?Perenlei Enkhbaatar
Critical Care Medicine|August 28, 2013
Beta-1 blockade in sepsis: what to expect?Perenlei Enkhbaatar
Critical Care Medicine|September 25, 2013
Activated protein C: from excitement to disappointment?Perenlei Enkhbaatar
Critical Care Medicine|June 20, 2012
Differential host response to Burkholderia pseudomallei: tissue plasminogen activator*Perenlei Enkhbaatar, Daniel L Traber
Clinical Science (London, England : 1979)|May 21, 2004
Pathophysiology of acute lung injury in combined burn and smoke inhalation injuryPerenlei Enkhbaatar, Daniel L Traber
Critical Care Medicine|April 7, 2007
Interleukin-1 in thermal injury: what is next?Perenlei Enkhbaatar, Lillian Traber, Daniel Traber
Critical Care Medicine|June 10, 2004
Protective role of myocardial heat shock protein 70 in burn trauma: another brick in the wall?Martin Westphal, Perenlei Enkhbaatar, Daniel L Traber
Critical Care (London, England)|August 21, 2009
Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?Sebastian Rehberg, Perenlei Enkhbaatar, Daniel L Traber
Critical Care Medicine|December 28, 2012
AMP-activated protein kinase signaling pathway in toxic smoke inhalation injury: nice to demonstrate, nice to know, but is there a therapeutic relevance?Sebastian Rehberg, Perenlei Enkhbaatar, Daniel L Traber
Critical Care (London, England)|October 3, 2008
Anticoagulant therapy in acute lung injury: a useful tool without proper operating instruction?Sebastian Rehberg, Perenlei Enkhbaatar, Daniel L Traber
Pageof 17